HAILEY ARENS: Open Payments
NPI 1700351376 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,381 in 55 payments from 14 companies in 2025. Trend: 2023 $2,574 · 2024 $1,335 · 2025 $1,381
Food & beverage: $1,282Education: $99
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $225 |
| Regeneron Healthcare Solutions, Inc. | 5 | $201 |
| ABBVIE INC. | 10 | $196 |
| Galderma Laboratories, L.P. | 7 | $170 |
| Lilly USA, LLC | 8 | $149 |
| Novartis Pharmaceuticals Corporation | 5 | $116 |
| UCB, Inc. | 3 | $66 |
| GENZYME CORPORATION | 2 | $61 |
| PFIZER INC. | 4 | $60 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
Products named: DUPIXENT, OTEZLA, SKYRIZI, COSENTYX, TALTZ, NEMLUVIO, Bimzelx, CIBINQO.
Industry payments across AR — which companies pay providers there.
